Depression, Anxiety, and Neurotransmitters:
Benekelfat, C. Mood lowering effect of tryptophan depletion. Archives of General Psychiatry 1994; 51: 687-97.
Brodie, H, et al. Clinical studies of L-5-hydroxytryptophan in depression. Serotonin and Behavior 1973: 549-59.
Delgado, P, et al. Role of Norepinephrine in Depression. Journal of Clinical Psychiatry 2000; 61 (suppl 1): 5-12.
Goldberg, I. Tyrosine and depression. Lancet 1980; 2:364.
Gelenberg A, et al. Tyrosine for depression: A double blind trial. Journal of Affective Disorders 1990; 19(2):125-132.
Kahn, R, et al. L-5-hydroxytryptophan in the treatment of anxiety disorders. Journal of Affective Disorders 1985; 8: 197-200.
Meltzer, H. et al. Fluoxetine, but not tricyclic antidepressants, potentiates the 5-hydroxytryptophan-mediated increase in plasma cortisol and prolactin secretion in subjects with major depression or with obsessive compulsive disorder. Neuropsychopharmacology 1997 July; 17(1):1-11.
Spillmann, MK, et a. Tryptophan depletion in selective serotonin reuptake inhibitor-recovered depressed patients. Psychopharmacology 2001 May; 155(2): 123-127.
Markus, CR, et al. Does carbohydrate rich, protein poor food prevent a deterioration of mood and cognitive performance. Appetite 1998 Aug; 31(1): 49-65.
Moller, S. Serotonin, Carbohydrates and Atypical Depression. Research Institute for Biologic Psychiatry, Department of Clinical Pharmacology, Denmark, pages 61-71.
Parrott, AC. Human Psychopharmacology of Ectasy (MDMA): a review of 15 years of empirical research. Human Pscyhopharmacology 2001 Dec; 16(8): 557-577.
Poldinger, W. et al. A functional approach to depression: serotonin deficiency as a target syndrome in a comparison of 5-hydroxytryptophan and fluoxamine. Psychopathology 1991; 24(2): 53-81.
Van Praag, H, et al. Depression vulnerability and 5-hydroxytryptophan prophylaxis. Psy Res 1980; 3: 75-83.
Wurtman, J. Depression and Weight Gain: the serotonin connection. Journal of Affective Disorders 1993; 29; 183-192.
